[go: up one dir, main page]

Follow
Alfredo Budillon
Alfredo Budillon
Istituto Tumori Napoli G. Pascale
Verified email at istitutotumori.na.it
Title
Cited by
Cited by
Year
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...
Nature medicine 21 (7), 795-801, 2015
12392015
Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3β-MCL-1 axis
M Elgendy, M Ciro, A Hosseini, J Weiszmann, L Mazzarella, E Ferrari, ...
Cancer cell 35 (5), 798-815. e5, 2019
3182019
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A Noto, C De Vitis, ME Pisanu, G Roscilli, G Ricci, A Catizone, ...
Oncogene 36 (32), 4573-4584, 2017
2022017
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
M Terranova-Barberio, S Thomas, N Ali, N Pawlowska, J Park, G Krings, ...
Oncotarget 8 (69), 114156, 2017
1982017
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine
M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007
1972007
New perspective for an old antidiabetic drug: metformin as anticancer agent
A Leone, E Di Gennaro, F Bruzzese, A Avallone, A Budillon
Advances in Nutrition and Cancer, 355-376, 2013
1922013
cAMP-dependent protein kinase: role in normal and malignant growth
YS Cho-Chung, S Pepe, T Clair, ADO Budillon, M Nesterova
Critical reviews in oncology/hematology 21 (1-3), 33-61, 1995
1921995
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1
D Melisi, Q Xia, G Paradiso, J Ling, T Moccia, C Carbone, A Budillon, ...
Journal of the National Cancer Institute 103 (15), 1190-1204, 2011
1892011
Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in …
E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ...
Journal of cellular physiology 195 (1), 139-150, 2003
1882003
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells
M Caraglia, M Marra, F Mancinelli, G D'ambrosio, R Massa, A Giordano, ...
Journal of cellular physiology 204 (2), 539-548, 2005
1802005
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
SS Faria, S Costantini, VCC de Lima, VP de Andrade, M Rialland, ...
Journal of Biomedical Science 28 (1), 26, 2021
1782021
The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma
A Guerra, MR Sapio, V Marotta, E Campanile, S Rossi, I Forno, ...
The Journal of Clinical Endocrinology & Metabolism 97 (2), 517-524, 2012
1762012
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi, G Tonini, A Budillon
Endocrine-related cancer 13 (1), 7-26, 2006
1732006
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15
F Bruzzese, C Hägglöf, A Leone, E Sjöberg, MS Roca, S Kiflemariam, ...
Cancer research 74 (13), 3408-3417, 2014
1642014
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
F Bruzzese, A Leone, M Rocco, C Carbone, G Piro, M Caraglia, ...
Journal of cellular physiology 226 (9), 2378-2390, 2011
1642011
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome
A Guerra, L Fugazzola, V Marotta, M Cirillo, S Rossi, V Cirello, I Forno, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), 2333-2340, 2012
1532012
Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches
A Leone, MS Roca, C Ciardiello, S Costantini, A Budillon
Oxidative Medicine and Cellular Longevity 2017 (1), 2597581, 2017
1472017
Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis
G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ...
The Journal of pathology 202 (3), 305-312, 2004
1452004
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
M Colone, A Calcabrini, L Toccacieli, G Bozzuto, A Stringaro, M Gentile, ...
Journal of Investigative Dermatology 128 (4), 957-971, 2008
1372008
Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients
R Bei, A Budillon, L Masuelli, V Cereda, D Vitolo, E Di Gennaro, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
1312004
The system can't perform the operation now. Try again later.
Articles 1–20